The Princess Royal Hospital is a teaching hospital located in Apley Castle, Telford, England. It forms the Telford site of the Shrewsbury and Telford Hospital NHS Trust and serves patients in Telford and Wrekin, the rest of Shropshire, and Powys, in conjunction with the Royal Shrewsbury Hospital.

There are 327 beds in Princess Royal Hospital.

During the past decade, Princess Royal Hospital conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Princess Royal Hospital" #1 sponsor was "Medical Research Council" with 2 trials, followed by "Boehringer Ingelheim" with 1 trials sponsored, "Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company" with 1 trials sponsored, "Gilead Sciences" with 1 trials sponsored and "Institute of Cancer Research, United Kingdom" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Princess Royal Hospital" #1 collaborator was "Barts & The London NHS Trust" with 1 trials as a collaborator, "Birmingham Women's NHS Foundation Trust" with 1 trials as a collaborator, "City Hospitals Sunderland NHS Foundation Trust" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Princess Royal Hospital" are "Atherosclerotic Cardiovascular Disease" (1 trials), "Bladder Cancer" (1 trials), "Breast Cancer" (1 trials), "Cardiovascular Diseases" (1 trials) and "Chronic Kidney Disease" (1 trials). Many other conditions were trialed in "Princess Royal Hospital" in a lesser frequency.

Most popular intervention types in "Princess Royal Hospital" are "Drug" (6 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Aromatase Inhibitors" (1 trials), "Empagliflozin" (1 trials), "Matching placebo" (1 trials), "Mifepristone, Oral, 200 Mg" (1 trials) and "Non-interventional" (1 trials). Other intervention names were less common.

The vast majority of trials in "Princess Royal Hospital" are 4 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Princess Royal Hospital". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Princess Royal Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Princess Royal Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".